István Gábor Takács is a human rights activist, videographer and trainer. He ran the Video Advocacy Program of the Hungarian Civil Liberties Union between 2007-2015. He worked as a needle exchange program counselor for 5 years. He is author of several articles on harm reduction and cameraman, editor, director and co-director of more than 700 online videos, among them longer documentaries, such as “Kostya Proletarsky” (2020), “Taking Back What’s Ours: An Oral History of the Movement of People who Use Drugs” (2020) ”A Day in the Life: The World of Humans Who Use Drugs” (2016), “Without Rights” (2009), “Without a Chance” (2014), “Room in the 8th District” (2014) and “The Invisible” (2011). Since 2016 he works at the Rights Reporter Foundation, where besides producing films, he is training activists in video advocacy.
A case study by our guest author David Haddad on Methoxetamine, misinformed media and prohibition as a failed approach towards New Psychoactive Substances.
A struggle for making medical cannabis legal in Poland: an article by Iga Jeziorska on our new video produced by Paweł Libera and the Polish Drug Policy Network.
Unlike other countries from the former Yugoslavia, Slovenia is experimenting with drug policy in order to improve the public health response to drug use. After almost two decades of advocacy and preparatory legal work, a drug consumption room (DCR) pilot project was launched in Ljubljana, in 2015, by the local NGO, 'Stigma'.
PKNI and Drugreporter launch their new documentary film in 4 cities across Indonesia ahead of World AIDS Day 2015. Watch and share the film to end the war on drugs in Indonesia!
In Slovakia, the cost/benefit analysis carried out on a needle and syringe exchange program showed that every euro invested in C.A. Odyseus´s harm reduction program generated benefits worth almost three euros. Read what the figures show about why it’s worthwhile investing in harm reduction!
Scientists at the University of Debrecen, Hungary, are aiming to work on cutting-edge research to study how endogenous DMT, occurring naturally in the body, may be useful to modern medicine, particularly by protecting brain cells in the stage of clinical death.
